424 Capital Makes Strategic Investment in VaLogic
November 29, 2023
424 Capital completed a significant investment in VaLogic, a Frederick, Maryland-based provider of GMP/GLP compliance software and life-science facility services. The capital will support VaLogic's growth plans—expanding services, markets and customer reach—while enabling pharmaceutical and biotechnology clients to focus on R&D and manufacturing with validated compliance tools (including VaLogic's LogiPoint SaaS).
- Buyers
- 424 Capital
- Targets
- VaLogic
- Industry
- Healthcare Services
- Location
- Maryland, United States
- Transaction Type
- Growth capital
Explore More
Related Acquisitions
-
Plexus Capital and 424 Capital Invest in VaLogic Bio
September 19, 2023
Healthcare Services
Plexus Capital and 424 Capital announced an investment in VaLogic Bio, a Frederick, Maryland-based provider of GMP compliance software and life-sciences laboratory services. The capital will support VaLogic’s continued growth of its facility monitoring SaaS and professional compliance services for FDA-regulated clients.
-
VaLogic Bio (424 Capital) Acquires Facility Logix
September 13, 2024
Healthcare Services
VaLogic Bio, a platform company of private equity firm 424 Capital, has acquired Facility Logix, a Burtonsville, Maryland-based firm specializing in planning, development, and project management for life-sciences facilities. The deal is an add-on acquisition intended to expand VaLogic Bio's service capabilities and build a full-service outsourced solutions platform for life sciences facility design, CQV, environmental monitoring, and ongoing compliance.
-
Northrim Horizon Makes Strategic Growth Investment in VLogic Systems
June 12, 2024
Cloud & SaaS
Northrim Horizon, a private equity firm, has made a strategic growth investment in VLogic Systems, a Concord, Massachusetts–based developer of a FedRAMP-authorized IWMS and Connected Portfolio Intelligence Platform (VLogicFM). The investment will support VLogic's product expansion, continued growth into federal and commercial markets, and scale its sales and hiring plans while management remains in place.
-
Ampersand Capital Partners Makes Growth Investment in Vibalogics GmbH
May 29, 2019
Biotechnology
Ampersand Capital Partners has made a growth equity investment in Vibalogics GmbH, a German CDMO specializing in development and GMP manufacturing of complex viral products. The investment will fund expansion of Vibalogics' process development and manufacturing capabilities and support broader growth in the U.S. and European markets.
-
VaLogic Bio Acquires Superior Laboratory Services, Inc.
August 1, 2024
Healthcare Services
VaLogic Bio, a Frederick, Maryland–based provider of GMP compliance and laboratory technology solutions, has acquired Superior Laboratory Services, Inc. (SLSI), a Pasadena, Texas lab design, construction and certification firm. The acquisition adds SLSI's two decades of laboratory design and USP/pharmaceutical laboratory expertise to VaLogic's service offerings and will keep the Pasadena office operational under VaLogic ownership.
-
QuVa Pharma Acquires LogicStream Health
July 25, 2024
Healthcare Services
QuVa Pharma acquired LogicStream Health, bringing the Minneapolis-based SaaS clinical intelligence platform into QuVa as a wholly owned subsidiary. The combination pairs QuVa's national sterile compounding and distribution capabilities with LogicStream's AI-driven pharmacy analytics to improve drug shortage prediction, formulary management, and clinical process insights for health system pharmacies.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.